These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
544 related items for PubMed ID: 32541753
1. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature. Kanwar N, Bakr MM, Meer M, Siddiqi A. Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753 [Abstract] [Full Text] [Related]
3. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I. Turner B, Drudge-Coates L, Ali S, Pati J, Nargund V, Ali E, Cheng L, Wells P. Urol Nurs; 2016 Jun; 36(3):111-6, 154. PubMed ID: 27501591 [Abstract] [Full Text] [Related]
4. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw. Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M, Hasegawa S, Okuyama Y, Ogino N, Yamauchi H, Kobashi Y, Yamazoe S, Munetomo Y, Mogami T, Nomura T. Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278 [Abstract] [Full Text] [Related]
11. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. J Oral Maxillofac Surg; 2022 May; 80(5):920-943. PubMed ID: 35300956 [Abstract] [Full Text] [Related]
12. Management of Medication-Related Osteonecrosis of the Jaw. Williams WB, O'Ryan F. Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735 [Abstract] [Full Text] [Related]
14. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Kawahara M, Kuroshima S, Sawase T. Int J Implant Dent; 2021 May 14; 7(1):47. PubMed ID: 33987769 [Abstract] [Full Text] [Related]
15. Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals. Acharya S, Patil V, Ravindranath V, Kudva A, Nikhil K. J Med Life; 2022 Mar 14; 15(3):368-373. PubMed ID: 35449990 [Abstract] [Full Text] [Related]
16. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events. Sacco R, Woolley J, Yates J, Calasans-Maia MD, Akintola O, Patel V. Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun 14; 131(6):650-659. PubMed ID: 33518491 [Abstract] [Full Text] [Related]
17. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review. Khominsky A, Lim M. Aust Dent J; 2018 Dec 14; 63(4):441-454. PubMed ID: 30144095 [Abstract] [Full Text] [Related]
18. The role of illicit drugs in developing medication-related osteonecrosis (MRONJ): a systematic review. Sacco R, Ball R, Barry E, Akintola O. Br J Oral Maxillofac Surg; 2021 May 14; 59(4):398-406. PubMed ID: 33789811 [Abstract] [Full Text] [Related]
19. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed]. Yoneda T. Clin Calcium; 2014 Mar 14; 24(3):407-15. PubMed ID: 24576938 [Abstract] [Full Text] [Related]
20. [Bisphosphonate-related osteonecrosis of the jaws]. Sogacheva VV, Syomkin VA. Stomatologiia (Mosk); 2022 Mar 14; 101(6):85-90. PubMed ID: 36562373 [Abstract] [Full Text] [Related] Page: [Next] [New Search]